Growth Metrics

ADC Therapeutics (ADCT) Intangibles: 2019-2023

Historic Intangibles for ADC Therapeutics (ADCT) over the last 3 years, with Sep 2023 value amounting to $12.4 million.

  • ADC Therapeutics' Intangibles fell 15.34% to $12.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $12.4 million, marking a year-over-year decrease of 15.34%. This contributed to the annual value of $14.4 million for FY2022, which is 5.73% up from last year.
  • As of Q3 2023, ADC Therapeutics' Intangibles stood at $12.4 million, which was down 8.70% from $13.5 million recorded in Q2 2023.
  • ADC Therapeutics' Intangibles' 5-year high stood at $14.6 million during Q3 2022, with a 5-year trough of $8,825 in Q2 2020.
  • In the last 3 years, ADC Therapeutics' Intangibles had a median value of $13.6 million in 2021 and averaged $13.3 million.
  • As far as peak fluctuations go, ADC Therapeutics' Intangibles spiked by 135,990.65% in 2021, and later dropped by 15.34% in 2023.
  • Over the past 5 years, ADC Therapeutics' Intangibles (Quarterly) stood at $9.4 million in 2019, then reached $9,814 in 2020, then skyrocketed by 135,583.72% to $13.6 million in 2021, then grew by 5.73% to $14.4 million in 2022, then decreased by 15.34% to $12.4 million in 2023.
  • Its Intangibles was $12.4 million in Q3 2023, compared to $13.5 million in Q2 2023 and $13.6 million in Q1 2023.